AbbVie Inc. (ABBV): A Bull Case Theory
We came across a bullish thesis on AbbVie Inc. (ABBV) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.
Abbvie Inc. (ABBV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 179,628 | $37,635,659 | +213% | 0.33% |
| 2. | Lee Munder Capital Group Lee Munder | 162,787 | $34,107,132 | -3% | 2.26% |
| 3. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 89,227 | $18,694,841 | -2% | 8.25% |
| 4. | Hourglass Capital Kenneth A. Moffet | 32,888 | $6,890,694 | -8% | 1.8% |
| 5. | Navellier & Associates Louis Navellier | 30,960 | $6,070,413 | -8% | 0.84% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | Officer | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | Officer | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | Officer | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $210.54 | 33,132 | 53,234 | 2025-03-31 | Filing | ||
| $209.49 | 25,700 | 86,366 | 2025-03-31 | Filing | ||
| $212.34 | 17,644 | 11,577 | 2025-03-14 | Filing | ||
| $210.53 | 6,168 | 388,929 | 2025-03-03 | Filing | ||
| $205.11 | 92,460 | 395,097 | 2025-02-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 145,878,142 | $30,564,388,367 | 0.64% | |
| 2. | 13,237,703 | $2,773,563,594 | 0.55% | |
| 3. | 8,850,246 | $1,854,303,542 | 0.62% | |
| 4. | 5,059,568 | $1,060,080,665 | 0.34% | |
| 5. | 4,103,600 | $859,786,272 | 0.61% |
News See All
ChatGPT Stock Advice: Top 12 Stock Recommendations
This article looks at ChatGPT Stock Advice: Top 12 Stock Recommendations.
Billionaire Ken Fisher's 10 Healthcare Stock Picks with Massive Upside Potential
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
AbbVie Inc. (NYSE:ABBV) Q1 2025 Earnings Call Transcript
Operator: Welcome to the AbbVie First Quarter 2025 Earnings Conference Call. All participants will be able to listen only until the question and answer portion of this call.
15 Best Dividend Stocks to Buy for Long-Term Passive Income
Passive income, which refers to money earned with little ongoing effort, was once largely the domain of the wealthy – those who could afford to invest in rental properties or build up portfolios that...
30 Growing Dividend Stocks with Low PE Ratios
Value stocks are enjoying a rare period of strength amid this year’s broader market downturn.
10 Best Stocks That Will Always Grow
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
Jim Cramer's Game Plan for Next Week: 25 Stocks in Focus
On Thursday, Jim Cramer, the host of Mad Money, walked viewers through what he described as an important week ahead for Wall Street, with earnings season hitting full stride and a flood of quarterly reports...
15 Best Large-Cap Value Stocks to Buy as the Recession Hits
Goldman Sachs highlighted that equities around the world traded in and out of a bear market — which is often defined as a 20% decline from the recent peak.
10 Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.